Clinical Trial Update: Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants. [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating pharmacokinetics, safety, and tolerability of ceftazidime-avibactam in neonates and infants; study terminated with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-negative Bacterial Infection

Drugs mentioned

• ceftazidime/avibactam (ceftazidime/avibactam)

Snippet

Sponsor: Pfizer | Conditions: Gram-negative Bacterial Infection | Phase 2 | Status: TERMINATED | Results posted: 2024-03-26